Lupin Ltd — Investor Relations & Filings
Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-05-05 | English | |
| Press Release | 2026-05-05 | English | |
| ESOP/ESOS/ESPS | 2026-05-04 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-28 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-23 | English | |
| Board Meeting — Board Meeting Intimation | 2026-04-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42186975 | Copy of Newspaper Publication | 2026-05-05 | English | ||
| 42195444 | Press Release | 2026-05-05 | English | ||
| 42205320 | ESOP/ESOS/ESPS | 2026-05-04 | English | ||
| 42196473 | Disclosure under SEBI Takeover Regulations | 2026-04-28 | English | ||
| 42164861 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-23 | English | ||
| 42272022 | Board Meeting — Board Meeting Intimation | 2026-04-22 | English | ||
| 42272037 | Board Meeting — Financial Results/Dividend/Other business matters | 2026-04-22 | English | ||
| 42183128 | Press Release | 2026-04-22 | English | ||
| 42202411 | General Updates | 2026-04-18 | English | ||
| 42205901 | Incorporation | 2026-04-17 | English | ||
| 42210266 | Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 2026-04-17 | English | ||
| 42198251 | Press Release | 2026-04-10 | English | ||
| 42174668 | ESOP/ESOS/ESPS | 2026-04-09 | English | ||
| 42179171 | Press Release | 2026-04-08 | English | ||
| 42187958 | Press Release | 2026-04-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
|
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals a…
|
ALEMBICLTD | IN | Manufacturing |
|
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and…
|
APLLTD | IN | Manufacturing |
|
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across mul…
|
ALIVUS | IN | Manufacturing |
Lupin Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61031/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61031 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61031 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61031 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61031}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lupin Ltd (id: 61031)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.